Howard I. Hoffen - 24 Sep 2021 Form 4 Insider Report for Amplitude Healthcare Acquisition Corp (JSPR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
28 Sep 2021, 16:32:58 UTC
Prior SEC filing
19 Aug 2021
Next SEC filing
04 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Howard Hoffen

Key filing fact

Howard I. Hoffen filed Form 4 for Amplitude Healthcare Acquisition Corp (JSPR) on 28 Sep 2021.

Key facts

  • This page summarizes Howard I. Hoffen's Form 4 filing for Amplitude Healthcare Acquisition Corp (JSPR).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 28 Sep 2021, 16:32.

Change

  • Previous filing in this sequence was filed on 19 Aug 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JSPR transaction

Voting Common Stock

Options Exercise

Transaction value
Shares
+2,300,000
Change %
Price
Shares after
2,300,000
Date
24 Sep 2021
Ownership
See Footnote
Footnotes
F1, F2, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JSPR transaction Derivative

Class B Common Stock

Disposed to Issuer

Transaction value
$0
Shares
+200,000
Change %
Price
$0.000000*
Shares after
0
Date
24 Sep 2021
Ownership
See Footnote
Underlying class
Class A Common Stock
Underlying amount
200,000
Exercise price
Footnotes
F1, F3, F4
JSPR transaction Derivative

Class B Common Stock

Options Exercise

Transaction value
Shares
+2,300,000
Change %
Price
Shares after
0
Date
24 Sep 2021
Ownership
See Footnote
Underlying class
Class A Common Stock
Underlying amount
2,300,000
Exercise price
Footnotes
F1, F2, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Howard I. Hoffen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

As described in the Issuer's registration statement on Form S-1 (File No. 333-234324) under the heading "Description of Securities--Founder Shares", the shares of Class B Common Stock will automatically convert into shares of Class A Common Stock at the time of the Issuer's initial business combination on a one-for-one basis, subject to certain adjustment described therein and have no expiration date.

Footnote F2

On September 24, 2021, Amplitude Healthcare Acquisition Corporation ("AMHC" and the former name of the Issuer) consummated its business combination with Jasper Therapeutics, Inc. (the former name of Jasper Tx Corp.). In connection with the business combination, each share of Class B Common Stock converted to one share of Voting Common Stock. The reporting person resigned as a director and as an officer of the Issuer upon consummation of the business combination.

Footnote F3

Pursuant to an agreement by and between the Issuer and Amplitude Healthcare Holdings LLC, concurrent with the consummation of the business combination, these shares of Class B Common Stock were forfeited to the Issuer as of immediately prior to the Merger.

Footnote F4

Amplitude Healthcare Holdings LLC, is the record holder of the shares reported herein. Mr. Hoffen may be deemed to share beneficial ownership of shares held by Amplitude Healthcare Holdings LLC. Mr. Hoffen disclaims beneficial ownership of the shares held by Amplitude Healthcare Holdings LLC except to the extent of his pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .